Skip to main content

Anesthesia, Local

0
Pipeline Programs
3
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Genomics
GenomicsUK - Oxford
4 programs
AG-920PHASE_31 trial
AG-920PHASE_31 trial
AG-920PHASE_31 trial
AG-920PHASE_31 trial
Active Trials
NCT05325853Completed61Est. May 2022
NCT05501860Completed249Est. Dec 2022
NCT04513652Completed120Est. Dec 2020
+1 more trials
UNION therapeutics
UNION therapeuticsDenmark - Hellerup
1 program
Combined anterior lumbar plexus and lateral sacral plexus block in a semi-supine positionN/A1 trial
Active Trials
NCT05901415Unknown30Est. Jun 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GenomicsAG-920
GenomicsAG-920
GenomicsAG-920
GenomicsAG-920
UNION therapeuticsCombined anterior lumbar plexus and lateral sacral plexus block in a semi-supine position

Clinical Trials (5)

Total enrollment: 580 patients across 5 trials

NCT05501860GenomicsAG-920

A Safety Study of of AG-920 Sterile Topical Ophthalmic Solution

Start: Jul 2022Est. completion: Dec 2022249 patients
Phase 3Completed
NCT05325853GenomicsAG-920

A Study of Safety and the Local Anesthetic Effect of AG-920 Ophthalmic Solution in a Pediatric Population

Start: Apr 2022Est. completion: May 202261 patients
Phase 3Completed
NCT04829344GenomicsAG-920

A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution

Start: Mar 2021Est. completion: May 2021120 patients
Phase 3Completed
NCT04513652GenomicsAG-920

A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution

Start: Sep 2020Est. completion: Dec 2020120 patients
Phase 3Completed
NCT05901415UNION therapeuticsCombined anterior lumbar plexus and lateral sacral plexus block in a semi-supine position

Modified LPB and SPB vs Classical LPB and SPB

Start: Aug 2023Est. completion: Jun 202530 patients
N/AUnknown

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.